China International Exhibition on Pharmaceutical Raw Materials

CPhI China, the world’s premier exhibition for pharmaceutical raw materials, serves as a key engine driving the transformation and upgrading of the global pharmaceutical industry, as well as an innovative platform for generating cutting-edge solutions. Leveraging its deep industry roots, forward-looking international perspective, and distinctive spirit of innovation, CPhI China continues to lead industry development. In tandem with the concurrently held “PMEC China,” the World Exhibition for Pharmaceutical Machinery, Packaging Equipment & Materials, CPhI China not only builds a comprehensive, end-to-end industrial ecosystem but also creates substantial business value and strategic opportunities through cutting-edge technology showcases, thought-provoking discussions, and efficient resource matchmaking, thereby injecting fresh momentum into the ongoing evolution of the pharmaceutical sector.

CPhI China is introducing six thematic zones: the International New Brands Zone, the Smart Laboratory Space, the Medical Aesthetics Packaging Materials Zone, the Traditional Chinese Medicine Herbs and Slices Zone, the Pharmaceutical–Medical Device Combination Zone, and the Cutting-Edge Technologies and Innovative Therapies Showcase Area. This strategic upgrade aligns closely with the pulse of global pharmaceutical industry development, precisely targeting the latest trends and innovation hotspots, with the aim of providing buyers with a more comprehensive and forward-looking procurement outlook while optimizing supply chain configurations.

Driven by a dual-engine approach—deep industry integration combined with broad cross-sector collaboration—CPhI China has meticulously curated over one hundred high-profile forums, bringing together leading authorities from regulatory agencies, distinguished academics, and prominent industry leaders. These forums will delve into critical topics such as policy and regulation, innovative R&D, market access, smart manufacturing, and green production processes, fostering deeper integration and synergistic development within the “Pharmaceutical+” ecosystem.

In June 2027, CPhI & PMEC China will undergo a major revitalization, relocating to the Shanghai National Exhibition and Convention Center in Hongqiao. Moving forward, the event will feature an expansive exhibition footprint and an exceptional international outlook, empowering collaborative industry upgrades and ushering in a new chapter of high-quality growth for the global pharmaceutical sector.

China International Exhibition on Pharmaceutical Raw Materials tickets are e-tickets. Mainland China visitors must complete online pre-registration with real-name ID verification; overseas visitors must use passport verification; Hong Kong, Macao, and Taiwan visitors must use their travel permit. On site, verify entry with your ID card or by scanning the e-ticket QR code.

Partial exhibitor directory and exhibitor list for China International Exhibition on Pharmaceutical Raw Materials: 河北维达康生物科技股份有限公司, 昆山诺凯特环保科技有限公司, 安徽安特食品股份有限公司, 广州虹科电子科技有限公司, 保定思诺流体科技有限公司, and others. The 2027 edition is expected to feature 500+ exhibiting companies. To obtain the full exhibitor directory (including booth numbers and contact details), please visit the official exhibition website or contact Jufair.

The Exhibition Value of CPHI China

• A Flagship Platform for the Global Pharmaceutical IndustryAs Asia’s largest specialized pharmaceutical event, it brings together over 3,600 exhibiting companies and more than 110,000 professional visitors from over 150 countries and regions, serving as a strategic platform for companies to showcase their capabilities and connect with global resources.
• One-Stop Coverage Across the Entire Industry ChainExhibits comprehensively cover 18 core sub‑sectors, including APIs, natural extracts, biotechnology, contract manufacturing, finished dosage forms, pharmaceutical machinery, packaging materials, laboratory instruments, and more, enabling efficient matchmaking between upstream and downstream players—from R&D innovation to large‑scale production.
• A Hub for International Resource NetworkingWith a steadily increasing share of international visitors, the show attracts buyers from traditional markets such as India, South Korea, Japan, Europe, and North America, as well as emerging markets along the Belt and Road Initiative. It provides domestic and international enterprises with an efficient pathway to deepen connections within global supply chains and optimize their international footprint.
• A Launchpad for Cutting‑Edge TechnologiesFocusing on前沿 areas such as biopharmaceuticals, peptide therapeutics, cell therapy, intelligent manufacturing, and green processes, the event showcases innovative raw materials and state‑of‑the‑art equipment. Specialized zones—including a debut brand incubation area, a Future Lab space, and a medical‑aesthetic packaging section—offer enterprises an authoritative stage to seize technological leadership.
• In‑Depth Empowerment Through High‑Level ForumsMore than a hundred concurrent conferences address pressing topics such as international expansion, the globalization of innovative drugs, regulatory guidance, natural extracts, and biopharmaceutical R&D, bringing together global regulators, research experts, and industry leaders to provide authoritative insights for strategic decision‑making.
• Precision Business Matching ServicesThrough initiatives like the “Natural Bridge” Global Buyer Matchmaking Program and dedicated overseas buyer sessions, the event facilitates one‑on‑one, precision‑driven connections, effectively advancing collaboration intentions. Overseas buyer delegations and VIP invitation programs further ensure tangible support for enterprises seeking to expand into global markets.
• A Catalyst for Industrial InnovationThe exhibition has witnessed and propelled China’s pharmaceutical industry in its transformation from a “global manufacturing base” to a “global value hub,” serving as a central nexus for linking Chinese pharmaceutical innovations to the global market and integrating them into the worldwide pharmaceutical supply chain.

Notable exhibitors

• International Pharmaceutical Giants: Merck, Catalent, Biocon, Teva, IFF, MERCK, DFE Pharma, Meggle, Capsugel, Croda China, KERRY, INDENA, Linnea, Cinnamon Lab
• Leading Domestic Comprehensive Players: Sinopharm Group, Fosun Pharma, Haizheng Pharmaceutical, Yiling Pharmaceutical, Sansheng National Health, Sinovac, Ganlee, Hanyu, Gute, Zhifei, Tebao, Jinsai Pharmaceutical, Maigao, Puli Pharmaceutical, Huateng Pharmaceutical, Shandong Pharmaceutical Glass Co., Ltd., Federal Pharmaceutical, Lizhu Pharmaceutical, Rundu Pharmaceutical, JinHong Pharmaceutical, Weilan Pharmaceutical, Jiuzhou Pharmaceutical
• Natural Extracts and Herbal Medicines: Chenguang Bio, Guilin Rhine, Yuwang Pharmaceutical, Haotian Pharmaceutical, Baihe Bio, Lüman Bio, Shuxi Pharmaceutical, Jiahe Bio, Lvzhijian, Huishong Pharmaceutical, Yunxing Bio, Chongqing Jiaowang, Yinuo Bio, Tianjin Jianfeng, Ciyuan Bio, Tianran Gu, Nuoyun Bio, Sinochem Health, Chengdu Oukang
• Contract Manufacturing and CDMO Services: Kailiying, Boteng, Yaoshi Technology, Haofan Bio, Chaorui Chemical, Chenchen Pharmaceutical, Nanjing Kelang, Liuhe Ningyuan, Shaoyuan Technology, Baonuo–Sandia, Wanbang Pharmaceutical, Mingjie Pharmaceutical, Huaxian Pharmaceutical, Chengdu Leadgene
• Pharmaceutical Excipients and Capsules: Shanhe Pharmaceutical Excipients, Guangsheng Capsules, Suzhou Capsules, Xinkaiyuan Pharmaceutical, Capsugel, Luofu Pharmaceutical, Qingdao Yiqing Bio, Aiweituo, Jiangsu Lifan Capsules
• Biotechnology and Cutting-Edge Innovations: Zhongtai Biochemical, Bei’anji, Xibao Bio, Medif, Maibang Bio